The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(benzo[d][1,3]dioxol-5-ylmethyl)-5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-amine ID: ALA4459594
Cas Number: 1030123-90-0
PubChem CID: 9196193
Product Number: A412954, Order Now?
Max Phase: Preclinical
Molecular Formula: C20H14FN3O2S
Molecular Weight: 379.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccc(-c2csc3ncnc(NCc4ccc5c(c4)OCO5)c23)cc1
Standard InChI: InChI=1S/C20H14FN3O2S/c21-14-4-2-13(3-5-14)15-9-27-20-18(15)19(23-10-24-20)22-8-12-1-6-16-17(7-12)26-11-25-16/h1-7,9-10H,8,11H2,(H,22,23,24)
Standard InChI Key: QGYLTGSHWIGJJD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
5.4435 -7.3945 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1532 -6.9851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1504 -6.1624 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4418 -5.7572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4393 -4.9400 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7355 -6.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7322 -6.1691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9546 -5.9199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4773 -6.5824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9600 -7.2410 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6990 -5.1437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2461 -4.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9910 -3.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1903 -3.5939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6450 -4.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9030 -4.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9336 -2.8180 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1458 -4.5293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1434 -3.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8517 -3.3059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4313 -2.4972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4369 -3.3123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1401 -2.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8453 -2.4913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4523 -1.9471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1224 -1.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3114 -1.2851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 7 1 0
4 5 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 6 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
5 18 1 0
18 19 1 0
19 20 2 0
20 24 1 0
23 21 1 0
21 22 2 0
22 19 1 0
23 24 2 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.42Molecular Weight (Monoisotopic): 379.0791AlogP: 4.84#Rotatable Bonds: 4Polar Surface Area: 56.27Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.92CX LogP: 4.50CX LogD: 4.50Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -1.52
References 1. Jiang ZY, Lu MC, You QD.. (2019) Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy., 62 (8): [PMID:30444366 ] [10.1021/acs.jmedchem.8b01121 ]